In focus
Latest feed
Unlocking Faster Drug Production: FDA Launches 'Precheck' for New Pharma Plants
The Surprising Calm: Why Healthcare ETFs Aren't Rattled by Pharma Price Cuts
CRISPR Therapeutics: Beyond the Hype, A Foundational Investment in Gene Editing's Future
A New Horizon for SMA Patients: Novartis's Groundbreaking Gene Therapy Gets FDA Nod